These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 11093063

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder.
    Greil W, Kleindienst N, Erazo N, Müller-Oerlinghausen B.
    J Clin Psychopharmacol; 1998 Dec; 18(6):455-60. PubMed ID: 9864077
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder.
    Kleindienst N, Greil W.
    Psychol Med; 2002 Apr; 32(3):493-501. PubMed ID: 11989994
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Vieta E, Cruz N, García-Campayo J, de Arce R, Manuel Crespo J, Vallès V, Pérez-Blanco J, Roca E, Manuel Olivares J, Moríñigo A, Fernández-Villamor R, Comes M.
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictors of response to mood stabilizers.
    Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ.
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):24S-31S. PubMed ID: 8707997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL.
    J Clin Psychiatry; 2003 Apr; 64 Suppl 5():38-43. PubMed ID: 12720483
    [Abstract] [Full Text] [Related]

  • 14. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?
    Kleindienst N, Greil W.
    J Clin Psychiatry; 2004 Jul; 65(7):966-74. PubMed ID: 15291686
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
    Fawcett J, Kravitz HM.
    J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046
    [Abstract] [Full Text] [Related]

  • 18. Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials.
    Ceron-Litvoc D, Soares BG, Geddes J, Litvoc J, de Lima MS.
    Hum Psychopharmacol; 2009 Jan; 24(1):19-28. PubMed ID: 19053079
    [Abstract] [Full Text] [Related]

  • 19. Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study.
    Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T.
    Eur Arch Psychiatry Clin Neurosci; 1997 Jan; 247(1):42-50. PubMed ID: 9088805
    [Abstract] [Full Text] [Related]

  • 20. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Jan; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.